AbbVie, Inc. (ABBV)
264.49
-0.47
(-0.18%)
USD |
NYSE |
Aug 24, 16:00
264.58
+0.09
(+0.03%)
After-Hours: 20:00
AbbVie Profit Margin (Quarterly) : 21.21% for June 30, 2026
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 21.21% |
| March 31, 2026 | 4.58% |
| December 31, 2025 | 10.86% |
| September 30, 2025 | 1.13% |
| June 30, 2025 | 6.04% |
| March 31, 2025 | 9.59% |
| December 31, 2024 | -0.22% |
| September 30, 2024 | 10.75% |
| June 30, 2024 | 9.42% |
| March 31, 2024 | 11.06% |
| December 31, 2023 | 5.68% |
| September 30, 2023 | 12.71% |
| June 30, 2023 | 14.54% |
| March 31, 2023 | 1.88% |
| December 31, 2022 | 16.35% |
| September 30, 2022 | 26.56% |
| June 30, 2022 | 6.29% |
| March 31, 2022 | 33.03% |
| December 31, 2021 | 27.03% |
| September 30, 2021 | 22.03% |
| June 30, 2021 | 5.39% |
| March 31, 2021 | 27.14% |
| December 31, 2020 | 0.16% |
| September 30, 2020 | 17.80% |
| June 30, 2020 | -7.26% |
| Date | Value |
|---|---|
| March 31, 2020 | 34.76% |
| December 31, 2019 | 32.03% |
| September 30, 2019 | 22.10% |
| June 30, 2019 | 8.88% |
| March 31, 2019 | 31.22% |
| December 31, 2018 | -21.94% |
| September 30, 2018 | 33.21% |
| June 30, 2018 | 23.83% |
| March 31, 2018 | 34.93% |
| December 31, 2017 | 0.67% |
| September 30, 2017 | 23.20% |
| June 30, 2017 | 27.45% |
| March 31, 2017 | 26.03% |
| December 31, 2016 | 20.36% |
| September 30, 2016 | 24.72% |
| June 30, 2016 | 24.83% |
| March 31, 2016 | 22.61% |
| December 31, 2015 | 23.58% |
| September 30, 2015 | 20.73% |
| June 30, 2015 | 24.82% |
| March 31, 2015 | 20.18% |
| December 31, 2014 | -14.77% |
| September 30, 2014 | 10.02% |
| June 30, 2014 | 22.15% |
| March 31, 2014 | 21.39% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Biogen, Inc. | 3.72% |
| Gilead Sciences, Inc. | -134.2% |
| Regeneron Pharmaceuticals, Inc. | 30.23% |
| Amgen, Inc. | 23.59% |
| REGENXBIO, Inc. | 21.02% |
Profit Margin (Quarterly) Related Metrics
| Return on Assets | 4.64% |
| Return on Invested Capital | 9.43% |
| Gross Profit Margin (Quarterly) | 74.71% |
| Operating Margin (Quarterly) | 39.54% |
| Return on Net Operating Assets | 5.60% |